๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Diverse approaches for the enhancement of oral drug bioavailability

โœ Scribed by Pius Fasinu; Viness Pillay; Valence M. K. Ndesendo; Lisa C. du Toit; Yahya E. Choonara


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
757 KB
Volume
32
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Enhanced oral bioavailability of doxorub
โœ Weilun Ke; Yansong Zhao; Rongqin Huang; Chen Jiang; Yuanying Pei ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 271 KB

PAMAM dendrimers can permeate across intestinal epithelial barriers suggesting their potential as oral drug carriers. In the present study, we have developed a drug-PAMAM complex for oral administration. The loading of a model drug, doxorubicin into PAMAM, the cellular uptake and pharmacokinetics of

Enhanced oral bioavailability of poorly
โœ Seong-Wan Cho; Jeoung Soo Lee; Seung-Ho Choi ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 182 KB

In this study, we attempted to improve the oral absorption of ceftriaxone (CTX) by using an absorption carrier and the CTX complex together. After the CTX-Cacarrageenan gel complex was prepared, several kinds of compounds (Capmul 1 MCM C10, Gelucire 44/14 1 , glycyrrhizin) were screened as potential

Enhancing the oral bioavailability of th
โœ Chris G. Thanos; Zhi Liu; Moses Goddard; Joshua Reineke; Nicola Bailey; Matthew ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 237 KB

This article investigates the effect of particle size and the incorporation of a bioadhesive polymer, poly(fumaric-co-sebacic) anhydride p(FA:SA), on the relative bioavailability of dicumarol. A novel method was used to reduce particle size of the drug, and encapsulated formulations were fabricated

Physical and biological considerations f
โœ David L. Pole ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 277 KB

This review addresses the use of nonaqueous solvents as components of oral formulations in discovery and preclinical studies. Pharmacology, pharmacokinetic, and safety studies are frequently conducted with solution formulations that use a solvent to solubilize poorly aqueous soluble drugs. The physi